CORD-19:e847d433e7424152a9846673209cb73027415ecd / 109073-109355 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1070","span":{"begin":0,"end":282},"obj":"Sentence"},{"id":"T73599","span":{"begin":0,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tigecycline was the most active antibiotic against MRSA and Enterococci with respect to linezolid (MIC 2 and 0.5 mg/L respectively) and quinopristin/dalfopristin (MIC 0.25 and 0.5 mg/L respectively), and with respect to macrolides, amoxicillin and tetracycline for all Streptococci."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T115","span":{"begin":0,"end":282},"obj":"Sentence"}],"text":"Tigecycline was the most active antibiotic against MRSA and Enterococci with respect to linezolid (MIC 2 and 0.5 mg/L respectively) and quinopristin/dalfopristin (MIC 0.25 and 0.5 mg/L respectively), and with respect to macrolides, amoxicillin and tetracycline for all Streptococci."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T359","span":{"begin":51,"end":55},"obj":"Disease"},{"id":"T58795","span":{"begin":51,"end":55},"obj":"Disease"}],"attributes":[{"id":"A359","pred":"mondo_id","subj":"T359","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A77036","pred":"mondo_id","subj":"T58795","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"Tigecycline was the most active antibiotic against MRSA and Enterococci with respect to linezolid (MIC 2 and 0.5 mg/L respectively) and quinopristin/dalfopristin (MIC 0.25 and 0.5 mg/L respectively), and with respect to macrolides, amoxicillin and tetracycline for all Streptococci."}